drugset / Trial / NCT03570554

A Pilot Study Assessing the Treatment Responsiveness of a Novel Osteoarthritis Stiffness Scale

NCT03570554

Phase 2 Completed 41 enrolled Bayer
RandomizedCrossoverQuadruple-blindTreatment

Summary

Osteoarthritis is a common, chronic, progressive, skeletal, degenerative disorder that frequently affects several joints such as knee, hip, spine and hands.This placebo-controlled clinical trial assessed the effects of naproxen sodium, acetaminophen and celecoxib on stiffness in subjects with osteoarthritis.

Timeline

Start
2018-06-29
Primary completion
2019-06-14
Completion
2019-06-14

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetaminophen Small molecule 3900 mg Oral
Subject Celecoxib Other / unclassified 200 mg Oral
Subject Naproxen Small molecule 660 mg Oral

Indications